https://sb431542inhibitor.com/....hgf-and-bfgf-release
DG's mechanism of action involved upregulating FXR and SHP expression and downregulating hepatic de novo lipogenesis genes like SREBP1C, ACC1, and FASN. DG, correspondingly, supported the expression of peroxisome proliferator-activated receptor alpha (PPAR), which is instrumental in the breakdown of fatty acids. Moreover, DG diminished the expression of the CD36 protein, which governs the transport of fatty
Like
Comment
Share
